Yunnan Baiyao Group Co., Ltd. at its Extraordinary General Meeting held on March 11, 2016, approved the appointment of Liu Jin as independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.88 CNY | -0.49% | -1.93% | +7.59% |
13/05 | Yunnan Baiyao's Unit to Conduct Clinical Trials on Prostate Cancer Drug | MT |
13/05 | Yunnan Baiyao to Conduct Clinical Trials on Flurbiprofen Gel Patch | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.59% | 1.3TCr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- 000538 Stock
- News Yunnan Baiyao Group Co.,Ltd
- Yunnan Baiyao Group Co., Ltd. Appoints Liu Jin as Independent Director